| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 908,171 | 973,431 | 1,321,454 | 1,521,649 | | Cost of Revenue | 293,534 | 289,529 | 1,387,011 | 632,557 | | | Gross Profit | 614,637 | 683,902 | (65,557) | 889,092 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 357,561 | 378,926 | (525,724) | 314,942 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 33,754 | 36,612 | 48,196 | 41,935 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 223,322 | 268,364 | 411,971 | 532,215 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (43,265) | (81,493) | 42,256 | 24,964 | | Earnings Before Interest And Taxes | 180,057 | 186,871 | 454,227 | 557,179 | | Interest Expense | 2,092 | 1,200 | 478 | 3,287 | | Income Before Tax | 177,965 | 185,671 | 453,749 | 553,892 | | Income Tax Expense | 67,159 | 64,771 | 153,260 | 150,580 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 110,806 | 120,900 | 300,489 | 403,312 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 110,806 | 120,900 | 300,489 | 403,312 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $110,806 | $120,900 | $300,489 | $403,312 |
|
0.45% Nasdaq 
0.20%
Income Statement
